大地國際集團(08130.HK)溢價逾倍發行代價股份購中國輻射檢驗業務60%股權
大地國際集團(08130.HK)公布,全資附屬眾投金服斥2,700萬元人民幣,收購標的公司之60%股權。相關公司於中國從事建設項目環境影響評價、竣工環境保護驗收、技術諮詢服務、輻射項目的檢驗檢測及山西省輻射工作人員的初級培訓。
代價中1,500萬元人民幣以現金支付,其餘則以發行代價股份支付,代價股份7,568.15萬股,佔公司擴大後股本2.08%。代價股份發行價0.188元,較公司上一個交易日收市價0.087元溢價1.16倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.